The FDA approved Epkinly in combination with other standard lymphoma drugs, rituximab + lenalidomide, for relapsed or ...

Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point for two distinct therapeutic pathways: Hodgkin’s lymphoma (HL) and ...

Patients with early-stage Hodgkin lymphoma had impressive response rates when treated with a novel combination of ...

Eli Lilly Canada, Inc announced today that Jaypirca® (pirtobrutinib, 100 mg & 50 mg tablets) is now approved and available ...

Marginal zone lymphoma treatment evolves with promising CAR T-cell therapies, addressing unmet needs in aggressive cases and improving patient outcomes.

BOSTON -- Researchers at the National Institutes of Health found a new treatment for lymphoma that is not chemotherapy. The recent study focused on a non-chemotherapy treatment for people with ...

In mantle cell lymphoma (MCL), an aggressive form of B-cell non-Hodgkin lymphoma, TP53 mutations are known to affect patients’ prognosis—but questions remain. What does the heterogeneity of TP53 ...

The U.S. Food and Drug Administration (FDA) has granted full approval of Laverdia, a drug to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system.

Emmy-nominated musician and songwriter Gabe Lopez, best known for his work on RuPaul’s Drag Race, died Sunday after a “brief but intense” lymphoma battle. Lopez’s mother, Connie Howard, confirmed the ...

The Global Peripheral T-Cell Lymphoma Market is poised for significant growth, driven by a rising incidence of lymphoma and adoption of novel targeted therapies and immunotherapies. Peripheral T-cell ...

On January 16, 2026, the U.S. Food and Drug Administration (FDA) released a statement saying they had granted full approval ...